Heart Failure With Mildly Reduced Ejection Fraction (HFmrEF): Clinical Trials

4 trials for Heart Failure With Mildly Reduced Ejection Fraction (HFmrEF), newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 not yet recruiting, 1 completed, 1 recruiting. 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 31Recruiting 1

Follow Heart Failure With Mildly Reduced Ejection Fraction (HFmrEF): new trials by email Literature Review of Heart Failure With Mildly Reduced Ejection Fraction (HFmrEF) trials Research Report on Heart Failure With Mildly Reduced Ejection Fraction (HFmrEF)

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
An AI-ECG-Based Approach for Dynamic Assessment of Heart Failure Risk and Myocardial Recovery Following Atrial Fibrillation Ablation
Atrial Fibrillation (AF), Heart Failure With Mildly Reduced Ejection Fraction (HFmrEF)
Not yet recruitingEwha Womans University Mokdong Hospital10002027-01-012026-07-20
A Study to Investigate CV Outcomes With Elecoglipron Compared With Placebo in Adult Participants With HFpEF or HFmrEF
Elecoglipron, Placebo - Heart Failure With Preserved Ejection Fraction (HFpEF), Heart Failure With Mildly Reduced Ejection Fraction (HFmrEF)
Phase 3RecruitingAstraZeneca69502026-08-242026-09-28
Precision Subtyping and Prognostic Study of Heart Failure Based on Multi-Omics Integration and Clinical Indicators: A Prospective Single-Center Cohort Study
Chronic Heart Failure, Heart Failure With Reduced Ejection Fraction (HFrEF)
Not yet recruitingXinjiang Medical University6002026-01-012026-01-21
Sodium-Glucose Cotransporter 2 Inhibitor Use in a National Heart Failure Telemonitoring Program
SGLT2 Inhibitor Use - Heart Failure, Heart Failure With Preserved Ejection Fraction (HFPEF)
CompletedSatelia136602021-01-012026-03-25

Narrower conditions

Heart Failure (2)  ·  Atrial Fibrillation (1)

Broader conditions

Cardiovascular Diseases (3)  ·  Heart Diseases (3)  ·  Arrhythmias, Cardiac (1)  ·  Pathologic Processes (1)  ·  Pathological Conditions, Signs and Symptoms (1)

Sponsors

AstraZeneca (1)  ·  Ewha Womans University Mokdong Hospital (1)  ·  Satelia (1)  ·  Xinjiang Medical University (1)

Countries

China (2)  ·  France (2)  ·  South Korea (2)  ·  Argentina (1)  ·  Australia (1)  ·  Austria (1)  ·  Brazil (1)  ·  Bulgaria (1)  ·  Canada (1)  ·  Czechia (1)  ·  Germany (1)  ·  Greece (1)  ·  Hungary (1)  ·  India (1)  ·  Italy (1)

Top investigators

Nicolas Girerd, PhD, MD (1)

Results publications

PMID 42480823